Nanometics LLC
Nanometics LLC, through its subsidiary PHD Biosciences, is dedicated to the development of innovative prescription and non-prescription topical products that bridge the fields of dermatology and oncology. With a focus on disruptive innovation, the company has achieved significant milestones, including thousands of prescriptions written annually and substantial non-dilutive funding since its founding in 2008.
The leadership team at PHD Biosciences comprises experts in drug development, regulatory affairs, and clinical operations, each bringing extensive experience from academia and the biopharmaceutical industry. Notable figures include Dr. Steven Isaacman, CEO, and Dr. Eric Rowinsky, Chief Medical Officer, both of whom have contributed significantly to the commercialization and registration of key oncology therapeutics.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.


